Cargando…
A guideline for the clinical management of basal cell naevus syndrome (Gorlin–Goltz syndrome)
Linked Comment: E. Epstein. Br J Dermatol 2022; 186:203. Plain language summary available online
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298899/ https://www.ncbi.nlm.nih.gov/pubmed/34375441 http://dx.doi.org/10.1111/bjd.20700 |
| _version_ | 1784750818844475392 |
|---|---|
| author | Verkouteren, B.J.A. Cosgun, B. Reinders, M.G.H.C. Kessler, P.A.W.K. Vermeulen, R.J. Klaassens, M. Lambrechts, S. van Rheenen, J.R. van Geel, M. Vreeburg, M. Mosterd, K. |
| author_facet | Verkouteren, B.J.A. Cosgun, B. Reinders, M.G.H.C. Kessler, P.A.W.K. Vermeulen, R.J. Klaassens, M. Lambrechts, S. van Rheenen, J.R. van Geel, M. Vreeburg, M. Mosterd, K. |
| author_sort | Verkouteren, B.J.A. |
| collection | PubMed |
| description | Linked Comment: E. Epstein. Br J Dermatol 2022; 186:203. Plain language summary available online |
| format | Online Article Text |
| id | pubmed-9298899 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92988992022-07-21 A guideline for the clinical management of basal cell naevus syndrome (Gorlin–Goltz syndrome) Verkouteren, B.J.A. Cosgun, B. Reinders, M.G.H.C. Kessler, P.A.W.K. Vermeulen, R.J. Klaassens, M. Lambrechts, S. van Rheenen, J.R. van Geel, M. Vreeburg, M. Mosterd, K. Br J Dermatol Evidence‐Based Dermatology Linked Comment: E. Epstein. Br J Dermatol 2022; 186:203. Plain language summary available online John Wiley and Sons Inc. 2021-11-08 2022-02 /pmc/articles/PMC9298899/ /pubmed/34375441 http://dx.doi.org/10.1111/bjd.20700 Text en © 2021 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Evidence‐Based Dermatology Verkouteren, B.J.A. Cosgun, B. Reinders, M.G.H.C. Kessler, P.A.W.K. Vermeulen, R.J. Klaassens, M. Lambrechts, S. van Rheenen, J.R. van Geel, M. Vreeburg, M. Mosterd, K. A guideline for the clinical management of basal cell naevus syndrome (Gorlin–Goltz syndrome) |
| title | A guideline for the clinical management of basal cell naevus syndrome (Gorlin–Goltz syndrome)
|
| title_full | A guideline for the clinical management of basal cell naevus syndrome (Gorlin–Goltz syndrome)
|
| title_fullStr | A guideline for the clinical management of basal cell naevus syndrome (Gorlin–Goltz syndrome)
|
| title_full_unstemmed | A guideline for the clinical management of basal cell naevus syndrome (Gorlin–Goltz syndrome)
|
| title_short | A guideline for the clinical management of basal cell naevus syndrome (Gorlin–Goltz syndrome)
|
| title_sort | guideline for the clinical management of basal cell naevus syndrome (gorlin–goltz syndrome) |
| topic | Evidence‐Based Dermatology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298899/ https://www.ncbi.nlm.nih.gov/pubmed/34375441 http://dx.doi.org/10.1111/bjd.20700 |
| work_keys_str_mv | AT verkouterenbja aguidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT cosgunb aguidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT reindersmghc aguidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT kesslerpawk aguidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT vermeulenrj aguidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT klaassensm aguidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT lambrechtss aguidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT vanrheenenjr aguidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT vangeelm aguidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT vreeburgm aguidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT mosterdk aguidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT verkouterenbja guidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT cosgunb guidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT reindersmghc guidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT kesslerpawk guidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT vermeulenrj guidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT klaassensm guidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT lambrechtss guidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT vanrheenenjr guidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT vangeelm guidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT vreeburgm guidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome AT mosterdk guidelinefortheclinicalmanagementofbasalcellnaevussyndromegorlingoltzsyndrome |